Nov 17, 2021
Nov 11, 2021
Nov 10, 2021
precision medicine has the potential to change the way we think about, identify and manage cancer care. the impact on both clinical research and patient care will grow as our understanding and technologies improve and precision medicine and biomarkers will transform the delivery of cancer care to benefit both patients and cancer care systems.
the european commission defined [2015] personalised medicine as “a model of medicine that uses the molecular profile [phenotypes and genotypes] for tailoring the right therapeutic strategy for the right person at the right time, and | or to determine the predisposition to disease and | or to deliver timely and targeted prevention” working in collaboration, we can greatly improve access to precision medicines and biomarkers, with a flexible regulatory framework that accelerates access, encouraging policies that invest in and support the use of precision medicines and biomarkers, and educating on the potential effectiveness and efficiency precision medicine and biomarkers can make in our health care system.
​
precision medicine is rapidly having an impact on how drugs are discovered and developed; how patients are diagnosed and treated; and how health care delivery is channeling its resources to maximize patient benefits. precision medicine is having an important impact in clinical care, the great potential to improve the quality of patient care and to help contain health care costs and it should be directed at individual patients through the practice of medicine rather than through regulatory action.
every november the cancer collaborative, in collaboration with the European Cancer Patients Coalition (ECPC) aims to raise awareness on the role of genetics and genomics in cancer, in educating patients, caregivers, families and advocating to policy and decision makers on the importance of genomic testing (molecular profiling or biomarker testing) through this month long campaign.
​
cancer treatments is focused on where the cancer is located in the body, with the advent of targeted therapies it is possible to treat cancer based on the molecular profile of the tumour regardless of where it is located in the body. this approach leads to higher response rates, lower toxicity profiles and better quality of life for Canadians living with cancer.
​
every year, throughout the month of november we aim to educate, raise and awareness and advocate for
- Increased access and decreased waiting times for high quality molecular testing to make personalized healthcare more of a reality across Canada;
- More information to educate and empower patients and caregivers around the potential and availability of molecular testing;
- A harmonized and more efficient regulatory framework across Canada which could increase access to, and potentially reduce the cost of, molecular testing.
cancer is a collection of related diseases that can occur almost anywhere in the body and is characterized by abnormal cell process involving uncontrolled cell growth and proliferation that alters normal cell behaviour. there are over 100 types of cancers, and in all types, cancer is caused when certain changes occur to genes that control the way cells function, especially how they grow and divide. when cells start to multiply and divide outside of the normal cell process and they start to invade surrounding tissue
the growing understanding of genetics and genomics, how they drive health, disease and drug response in each person has created a pathway for precision medicine, moving away from the traditional one size fits all approach to medicine, to a more precise, predictable and cost effective healthcare system
07
Ce #géNOMBRE Les groupes canadiens contre le cancer s'unissent pour accélérer la médecine de précision au Canada
November 1, 2024
06
THIS #KNOWVEMBER CANADIAN PATIENT GROUPS UNITE TO ACCELERATE PRECISION MEDICINE IN CANADA
November 1, 2024
05
CAR-T CENTRES READY TO RECEIVE PATIENTS BUT HAVE NO TREATMENT TO OFFER
September 5, 2019
03
CAR-T HOW MUCH LONGER MUST CANADIANS WAIT
November 4, 2019
04
TREATING THE PATIENT NOT THE CANCER
October 31, 2019
02
#CRACKINGTHECANCERCODE
November 2, 2020
01
PRECISION MEDICINE AWARENESS MONTH RETURNS IN 2021
October 29, 2021